Key Points
- Insider sale: Anastasiia Kotaieva sold 38,744 shares on Dec. 18 at $4.72 ($182,871.68) and 70,000 shares on Dec. 19 at $4.53 ($317,100), totaling 108,744 shares (about $499,972) and reducing her stake by 2.64% to 1,431,197 shares valued at roughly $6.76M.
- Company context: Nukkleus (NASDAQ:NUKK) has a market cap of about $73.9M, a PE of 0.27 and a 52‑week range of $3.31–$50.87, and carries a consensus analyst rating of "Sell" despite a recent upgrade by Wall Street Zen to "Hold."
Nukkleus Inc. (NASDAQ:NUKK - Get Free Report) insider Anastasiia Kotaieva sold 38,744 shares of the business's stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $4.72, for a total value of $182,871.68. Following the sale, the insider owned 1,431,197 shares in the company, valued at $6,755,249.84. The trade was a 2.64% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Anastasiia Kotaieva also recently made the following trade(s):
- On Friday, December 19th, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The shares were sold at an average price of $4.53, for a total transaction of $317,100.00.
Nukkleus Stock Up 0.5%
NUKK stock opened at $4.44 on Tuesday. The stock has a market capitalization of $73.93 million, a PE ratio of 0.27 and a beta of -6.74. Nukkleus Inc. has a 52 week low of $3.31 and a 52 week high of $50.87. The firm has a 50 day moving average of $6.47 and a 200 day moving average of $7.15.
Analyst Ratings Changes
Several equities analysts recently issued reports on NUKK shares. Wall Street Zen raised Nukkleus from a "sell" rating to a "hold" rating in a research report on Sunday, November 23rd. Weiss Ratings reiterated a "sell (d)" rating on shares of Nukkleus in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has a consensus rating of "Sell".
Read Our Latest Analysis on NUKK
Institutional Trading of Nukkleus
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. BNP Paribas Financial Markets acquired a new position in Nukkleus during the second quarter valued at $56,000. Ausdal Financial Partners Inc. purchased a new position in shares of Nukkleus during the 3rd quarter valued at about $105,000. Finally, UBS Group AG raised its stake in shares of Nukkleus by 23.3% during the 3rd quarter. UBS Group AG now owns 80,512 shares of the company's stock valued at $564,000 after buying an additional 15,223 shares during the last quarter. Institutional investors and hedge funds own 12.47% of the company's stock.
About Nukkleus
(
Get Free Report)
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
